Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 53 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 8039008

    Identification of residues critical for the function of the vibrio cholerae virulence regulator ToxT by scanning alanine mutagenesis

    The Board of Regents of the University of Texas System · Granted Oct 18, 2011 · Expires Oct 13, 2031

    granted

  2. US 8034768

    Composition and method for the treatment of diseases affected by histone deacetylase inhibitors

    The Board of Regents of the University of Texas System · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  3. US 8030447

    Substrate peptide sequences for plague plasminogen activator and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted

  4. US 8021831

    Taxane chemosensitivity prediction test

    The Board of Regents of the University of Texas System · Granted Sep 20, 2011 · Expires Sep 15, 2031

    granted

  5. US 8013015

    Small molecule inhibitors of ghrelin O-acyltransferase

    The Board of Regents of the University of Texas System · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  6. US 8012476

    Molecules with extended half-lives, compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted

  7. US 8003692

    Methods and compositions to inhibit edema factor and adenylyl cyclase

    The Board of Regents of the University of Texas System · Granted Aug 23, 2011 · Expires Aug 18, 2031

    granted

  8. US 7994150

    Micro-RNAs that modulate smooth muscle proliferation and differentiation and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 9, 2011 · Expires Aug 4, 2031

    granted

  9. US 7981618

    Diagnostic and therapeutic methods and compositions involving PTEN and breast cancer

    The Board of Regents of the University of Texas System · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  10. US 7981935

    Stem cell differentiating agents and uses therefor

    The Board of Regents of the University of Texas System · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  11. US 7976868

    Liposomes comprising duramycin and anti-viral agents

    The Board of Regents of the University of Texas System · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  12. US 7976743

    Gas-containing liposomes

    The Board of Regents of the University of Texas System · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  13. US 7968115

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  14. US 7960133

    Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase

    The Board of Regents of the University of Texas System · Granted Jun 14, 2011 · Expires Jun 9, 2031

    granted

  15. US 7951356

    Tissue factor compositions and kits for coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted May 31, 2011 · Expires May 26, 2031

    granted

  16. US 7951362

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    The Board of Regents of the University of Texas System · Granted May 31, 2011 · Expires May 26, 2031

    granted

  17. US 7943332

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted May 17, 2011 · Expires May 12, 2031

    granted

  18. US 7928062

    Methods for selectively inhibiting Janus tyrosine kinase 3 (Jak3)

    The Board of Regents of the University of Texas System · Granted Apr 19, 2011 · Expires Apr 14, 2031

    granted

  19. US 7923548

    Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1

    The Board of Regents of the University of Texas System · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  20. US 7923014

    Expression and purification of HIP/PAP and uses therefor

    The Board of Regents of the University of Texas System · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  21. US 7923010

    Methods and materials for treating autoimmune diseases and conditions

    The Board of Regents of the University of Texas System · Granted Apr 12, 2011 · Expires Apr 7, 2031

    granted

  22. US 7919579

    Imaging and therapeutic targeting of prostate and bladder tissues

    The Board of Regents of the University of Texas System · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  23. US 7919613

    RNAi modulation of SCAP and therapeutic uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  24. US 7915245

    Methods and compositions of trail-death receptor agonists/activators

    The Board of Regents of the University of Texas System · Granted Mar 29, 2011 · Expires Mar 24, 2031

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.